NO864139D0 - Polypeptid virksomt ved dannelse av aids-antistoff. - Google Patents

Polypeptid virksomt ved dannelse av aids-antistoff.

Info

Publication number
NO864139D0
NO864139D0 NO864139A NO864139A NO864139D0 NO 864139 D0 NO864139 D0 NO 864139D0 NO 864139 A NO864139 A NO 864139A NO 864139 A NO864139 A NO 864139A NO 864139 D0 NO864139 D0 NO 864139D0
Authority
NO
Norway
Prior art keywords
creation
polypeptide effective
aids antibody
aids
antibody
Prior art date
Application number
NO864139A
Other languages
English (en)
Other versions
NO864139L (no
Inventor
Wilhelm Bannwarth
Ulrich Certa
Jan Mous
Dietrich Stueber
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO864139D0 publication Critical patent/NO864139D0/no
Publication of NO864139L publication Critical patent/NO864139L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
NO864139A 1985-10-17 1986-10-16 Polypeptid virksomt ved dannelse av aids-antistoff. NO864139L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858525615A GB8525615D0 (en) 1985-10-17 1985-10-17 Polypeptides

Publications (2)

Publication Number Publication Date
NO864139D0 true NO864139D0 (no) 1986-10-16
NO864139L NO864139L (no) 1987-04-21

Family

ID=10586812

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864139A NO864139L (no) 1985-10-17 1986-10-16 Polypeptid virksomt ved dannelse av aids-antistoff.

Country Status (11)

Country Link
EP (1) EP0219106A3 (no)
JP (1) JPS6299398A (no)
AU (1) AU602315B2 (no)
BR (1) BR8605053A (no)
DK (1) DK496486A (no)
ES (7) ES2009210A6 (no)
GB (1) GB8525615D0 (no)
IL (1) IL80304A0 (no)
NO (1) NO864139L (no)
NZ (1) NZ217895A (no)
ZA (1) ZA867748B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76082A (en) * 1984-08-22 1991-07-18 Us Health Molecular clones of the genome of htlv-iii and a process for the preparation thereof
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
DE3789633T2 (de) * 1986-05-27 1994-08-04 Hoffmann La Roche HTLV-III(LAV)Decke-Peptide.
EP0269712A4 (en) * 1986-06-12 1990-06-26 Biogen Nv PEPTIDES INVOLVED IN THE PATHOGENESIS OF A HIV TYPE INFECTION.
US5087557A (en) * 1986-06-23 1992-02-11 Genetic Systems Corporation Human monoclonal antibody to lymphadenopathy-associated virus
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
IL87391A0 (en) * 1987-08-27 1989-01-31 Repligen Corp Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
EP0323157A3 (en) * 1987-12-24 1990-07-25 The University Of Melbourne Antiviral compounds and methods
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
US6218102B1 (en) * 1988-01-27 2001-04-17 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
SE8802176D0 (sv) * 1988-06-10 1988-06-10 Kabigen Ab Fusion protein and its use
IL91462A0 (en) * 1988-08-30 1990-04-29 Applied Research Systems Recombinant fusion proteins and dna encoding for such a protein
EP0361749B1 (en) * 1988-09-27 1995-02-08 Dana Farber Cancer Institute A vector comprising a replication competent HIV-I provirus and a heterologous gene
US6228608B1 (en) * 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
US6316004B1 (en) * 1993-06-22 2001-11-13 T. Tikhonenko Chimeric somatostatin containing protein and encoding DNA, plasmids of expression, method for preparing chimeric protein, strain-producers, immunogenic composition, method for increasing the productivity of farm animals
IT1271486B (it) * 1993-10-12 1997-05-28 Italfarmaco Spa Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
FR2732346B1 (fr) * 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
AU2790899A (en) * 1998-03-04 1999-09-20 Universal Health-Watch, Inc. Rapid confirmatory test for microbial infections
DE60336978D1 (de) * 2003-04-11 2011-06-16 Pasteur Institut Synthetische Peptid-HIV-Vakzine: das CBD-Epitop als effizientes Immunogen zur Induktion HIV-neutralisierender Antikörper
WO2005115992A1 (en) 2004-05-23 2005-12-08 Housey Pharmaceuticals, Inc. Theramutein modulators
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
ATE250083T1 (de) * 1984-10-18 2003-10-15 Pasteur Institut Lav-antigene und -peptide
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
DE3650175T3 (de) * 1985-04-29 2007-09-06 Bio-Rad Laboratories, Inc., Hercules Synthetische antigene zum nachweis von aids.

Also Published As

Publication number Publication date
ZA867748B (en) 1987-07-29
GB8525615D0 (en) 1985-11-20
DK496486D0 (da) 1986-10-16
ES2009905A6 (es) 1989-10-16
DK496486A (da) 1987-04-18
NO864139L (no) 1987-04-21
ES2014527A6 (es) 1990-07-16
EP0219106A3 (en) 1989-02-08
AU6399786A (en) 1987-04-30
IL80304A0 (en) 1987-01-30
ES2006925A6 (es) 1989-05-16
NZ217895A (en) 1991-05-28
EP0219106A2 (en) 1987-04-22
ES2009906A6 (es) 1989-10-16
JPS6299398A (ja) 1987-05-08
ES2010538A6 (es) 1989-11-16
ES2009907A6 (es) 1989-10-16
BR8605053A (pt) 1987-07-14
ES2009210A6 (es) 1989-09-16
AU602315B2 (en) 1990-10-11

Similar Documents

Publication Publication Date Title
NO864139D0 (no) Polypeptid virksomt ved dannelse av aids-antistoff.
FI852516A0 (fi) Anordning foer dosering av tillvaext befraemjande aemnen.
DE3786767T2 (de) Neues Polypeptid.
FI862231A0 (fi) Anordning foer utkastning av spelbollar.
FI862761A0 (fi) Klonad antigen.
DE3689738T2 (de) Warmverdichtung von Balgbehältern.
IT8421622A0 (it) Procedimento per la preparazione di peptidi.
DK383985A (da) Polypeptid
DK354389D0 (da) Polypeptid
DK551287D0 (da) Polypeptid
NO861772L (no) Fremgangsmaate for fremstilling av proteinhydrolysat.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO860794L (no) Fremgangsmaate ved fremstilling av klordioksyd.
FI862023A0 (fi) Kontrollanordning i malmaskin.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
NO864386L (no) Fremgangsmaate ved fremstilling av uretaner.
NO861239L (no) Fremgangsmaate ved fremstilling av klordioksyd.
FI852772A0 (fi) Formsten.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO864087D0 (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO166709C (no) Fremgangsmaate for fremstilling av akrylamider.
FI853918A0 (fi) Anordning foer inriktning av cylinderformade mantlar.
NO904825D0 (no) Mellomprodukter for fremstilling av imidazopyridaziner.
FI851780A0 (fi) Anordning foer underlaettande av tvaett.
FI852919A0 (fi) Anordning foer avlaegsnande av goedsel.